Literature DB >> 20505954

Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease.

Lauren J Becton1, Ram V Kalpatthi, Elizabeth Rackoff, Deborah Disco, John K Orak, Sherron M Jackson, Ibrahim F Shatat.   

Abstract

Sickle cell disease (SCD) is associated with a large spectrum of renal abnormalities, one of which, microalbuminuria/proteinuria (MA/P), is a known predictor of end-stage renal disease. We studied 90 children with SCD (57% male; mean age 11.4 +/- 5.2 years) to determine the prevalence and examine clinical correlates of MA/P. The average of two spot urine microalbumin-to-creatinine samples obtained 6 months apart was recorded. Medical records were reviewed for demographic and biochemical data. Medication use, resting office blood pressures (BP), vaso-occlusive pain crises (VOC), and monthly transfusions were recorded. Fourteen children (15.5%) had MA/P. Hemoglobin (Hb) levels were significantly lower in the children with MA than in those without MA/P (8.8 +/- 1.1 vs. 9.8 +/- 1.4 g/dL, respectively) and were significantly correlated with MA (rho = 0.24, p = 0.03). Children with MA were more likely to have abnormal BP (p = 0.058), with 5/14 being hypertensive or pre-hypertensive. In a multivariate logistic regression model of MA, both Hb and BP classification remained in the final model. MA is a simple screening biomarker of early kidney injury in children with SCD. Larger studies to evaluate predictive factors of MA and the relationship to BP are needed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505954     DOI: 10.1007/s00467-010-1536-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  26 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Effects of nonsteroidal antiinflammatory drugs on renal function in sickle cell anemia.

Authors:  M Allon; L Lawson; J R Eckman; V Delaney; E Bourke
Journal:  Kidney Int       Date:  1988-10       Impact factor: 10.612

3.  Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia.

Authors:  E Voskaridou; E Terpos; S Michail; E Hantzi; A Anagnostopoulos; A Margeli; D Simirloglou; D Loukopoulos; I Papassotiriou
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

4.  Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.

Authors:  T R Kinney; R W Helms; E E O'Branski; K Ohene-Frempong; W Wang; C Daeschner; E Vichinsky; R Redding-Lallinger; B Gee; O S Platt; R E Ware
Journal:  Blood       Date:  1999-09-01       Impact factor: 22.113

5.  Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients.

Authors:  Darleen R Powars; Linda S Chan; Alan Hiti; Emily Ramicone; Cage Johnson
Journal:  Medicine (Baltimore)       Date:  2005-11       Impact factor: 1.889

6.  Early blood transfusions protect against microalbuminuria in children with sickle cell disease.

Authors:  Ofelia Alvarez; Brenda Montane; Gabriela Lopez; James Wilkinson; Tracie Miller
Journal:  Pediatr Blood Cancer       Date:  2006-07       Impact factor: 3.167

7.  Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease.

Authors:  Vikram Datta; Janaki Raju Ayengar; Shilpaja Karpate; Pushpa Chaturvedi
Journal:  Indian J Pediatr       Date:  2003-04       Impact factor: 1.967

8.  Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome.

Authors:  Jane Hankins; Michael Jeng; Sylvia Harris; Chin-Shang Li; Tiebin Liu; Winfred Wang
Journal:  J Pediatr Hematol Oncol       Date:  2005-03       Impact factor: 1.289

9.  Proteinuria in children with sickle cell disease.

Authors:  Olivera Marsenic; Kevin G Couloures; Joseph M Wiley
Journal:  Nephrol Dial Transplant       Date:  2007-12-08       Impact factor: 5.992

10.  Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality.

Authors:  D R Powars; D D Elliott-Mills; L Chan; J Niland; A L Hiti; L M Opas; C Johnson
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

View more
  38 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

2.  Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice.

Authors:  Malgorzata Kasztan; Brandon M Fox; Jeffrey D Lebensburger; Kelly A Hyndman; Joshua S Speed; Jennifer S Pollock; David M Pollock
Journal:  Blood Adv       Date:  2019-05-14

Review 3.  Measuring success: utility of biomarkers in sickle cell disease clinical trials and care.

Authors:  Ram Kalpatthi; Enrico M Novelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

4.  Severe anemia early in life as a risk factor for sickle-cell kidney disease.

Authors:  Inmaculada Aban; Sujatha Baddam; Lee M Hilliard; Thomas H Howard; Daniel I Feig; Jeffrey D Lebensburger
Journal:  Blood       Date:  2016-12-05       Impact factor: 22.113

5.  Chronic kidney disease and albuminuria in children with sickle cell disease.

Authors:  Marianne McPherson Yee; Shameem F Jabbar; Ifeyinwa Osunkwo; Lisa Clement; Peter A Lane; James R Eckman; Antonio Guasch
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-22       Impact factor: 8.237

Review 6.  Newborn screening and renal disease: where we have been; where we are now; where we are going.

Authors:  J Lawrence Merritt; David Askenazi; Si Houn Hahn
Journal:  Pediatr Nephrol       Date:  2011-09-27       Impact factor: 3.714

7.  Sickle cell trait and renal disease among African American U.S. Army soldiers.

Authors:  Jiaqi Hu; D Alan Nelson; Patricia A Deuster; Eric S Marks; Francis G O'Connor; Lianne M Kurina
Journal:  Br J Haematol       Date:  2019-03-11       Impact factor: 6.998

8.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

Authors:  Allison E Ashley-Koch; Emmanuel C Okocha; Melanie E Garrett; Karen Soldano; Laura M De Castro; Jude C Jonassaint; Eugene P Orringer; James R Eckman; Marilyn J Telen
Journal:  Br J Haematol       Date:  2011-09-13       Impact factor: 6.998

9.  Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.

Authors:  Santosh L Saraf; Xu Zhang; Tamir Kanias; James P Lash; Robert E Molokie; Bharvi Oza; Catherine Lai; Julie H Rowe; Michel Gowhari; Johara Hassan; Joseph Desimone; Roberto F Machado; Mark T Gladwin; Jane A Little; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2013-12-12       Impact factor: 6.998

10.  Masked hypertension is prevalent in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study.

Authors:  Ibrahim F Shatat; Sherron M Jakson; Amanda E Blue; Mary A Johnson; John K Orak; Ram Kalpatthi
Journal:  Pediatr Nephrol       Date:  2012-08-11       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.